4/23/2020SAMR Continues Focus on Pharma Sector Amid Covid-19 Outbreak, Fining A...

4/23/2020Henlius and Accord Receive Positive CHMP Opinion for Oncology Biosimil...

4/23/2020NPC to Review Several Public Health Related Bills

4/23/2020CStone's First Chinese NDA for Anticancer Avapritinib Accepted

4/23/2020Everest Med Approved for Clinical Trial of Sacituzumab in China

4/22/2020China Likely to Pull Some Drugs Out of the NRDL Soon

4/22/2020NMPA Publicizes List of Reference Formulations for Generic Drug Equiva...

4/22/2020Innovent Biologics Announces USFDA Approval of Pemazyre (Pemigatinib)

4/21/2020PwC: 2019 An Active Year in Chinese Pharma M&A

4/21/2020New Report: Cascading Economic Impacts of the COVID-19 Outbreak in Chi...

4/21/2020XiAn Janssen Launches Psoriasis Drug Tremfya (Geselkumab) in China

4/21/2020BeiGene's sNDA for Tislelizumab in Combo with NSCLC Chemotherapy in Ch...

4/21/2020Coronavirus Puts Big Pharma’s IP Regime to the Test

4/20/2020IQVIA: Chinese Retail Pharmacy Sales Up 3.9% in 2019

4/20/2020IQVIA: Urban Chinese Hospital Drug Market Up 9.4% in 2019

4/20/2020Chi-Med's Surufatinib Granted US Fast Track Designations

4/20/2020NH's DB6: Chinese OTC Drug Market Forecast 2019-2028

4/17/2020Recent Executive Moves

4/17/2020NMPA Publishes the List of Reference Formulations for Generic Drug Equ...

4/17/2020AmCham Survey: Supply Chain Challenges for US Companies in China

4/17/2020Dynavax and Sinovac Announce Collaboration to Develop a COVID-19 Vacci...

4/16/2020Zai Lab Granted Priority Review of sNDA for ZEJULA (Niraparib) for Fir...

4/16/2020Fosun Unit Receives Import Approval of Dova's CLD Drug Avatrombopag

4/16/2020Chinese Patent Applications on Inventions for Pharmaceutical Use (The ...

4/16/2020China to Experiment Internet Healthcare Expansion at Six Provincial Le...

4/16/2020NMPA Publishes the List of Reference Formulations for Generic Drug Equ...

4/16/2020CDE Solicits Public Comments for Clinical Research Guidelines for Pert...

4/15/2020Active Motif Licenses Four Antibodies to BioRay

4/15/2020Harbour BioMed Granted IND Approval to Begin Phase 2/3 Clinical Trial ...

4/15/2020Chinese Investors Maintains Appetite for Biopharma and Medtech with Qi...

Page:272/806 Total number of articles:24163: [First][<<] [270] [271] [272] [273] [274] [>>] [End]